Delivery Order SPE2DB22D2206-SPE2DB24FHM59
- Not listed
- This federal contract award, valued at $8,970.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GAMMAGARD S-D 10 G (IGA), a prescription pharmaceutical product, with a completion date of June 7, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Department of Veterans Affairs...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,485.20 firm-fixed-price contract is for the supply of GAMMAGARD S-D 10 G (IGA), a specialty pharmaceutical product. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen Drug Corp is a large for-profit organization that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $8,625.20 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide GAMMAGARD S-D 10 G (IGA) pharmaceutical products. Performance will occur in Conshohocken, Pennsylvania under a July 6th to 27th period of performance. The Defense Logistics Agency Troop Support Medical supports Department of Defense health care requirements, and this...
- This federal contract award, valued at $36,068.40, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the pharmaceutical product GAMUNEX-C, a 10 gram/100 ml vial. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,063.96 to AmerisourceBergen Drug Corp for GAMMAGARD S-D 10 G (IGA) on November 3, 2025, with completion targeted for November 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $9,017.10 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2024 and a fixed-price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,307.40 to AmerisourceBergen Drug Corp for the supply of Gammagard Liquid 10% in 200ML vials. The contract, awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, operates under firm fixed pricing with no set-aside designation. This delivery order is a competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML to the Defense Logistics Agency (DLA). The $14,295.00 firm fixed-price delivery order has a completion date of June 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $28,854.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution services company. The delivery order is for the product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML and has a period of performance through April 1, 2024. This award is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $2,382.50 firm fixed price delivery order is for the supply of GAMUNEX-C 20 gram/200 ml vial pharmaceutical products. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as Amerisourcebergen's primary vehicle for providing pharmaceuticals...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHM59Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $13,455.60, is for the delivery of GAMMAGARD S-D 10 G (IGA pharmaceutical products. The contract was awarded on a Firm Fixed Price basis and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 5/30/24 |